Update on Detection of Existing Influenza A Variant
Singapore, December 6, 2023 – Update on the Detection of Existing Influenza A Variant Credo Diagnostics Biomedical Pte. Ltd. is committed to the post-market monitoring of the reliability of our assays. We have performed nucleotide analysis using the BLASTn method, comparing primers and probes of the assays involving influenza A virus detection to all sequences […]
